Literature DB >> 8899075

Review article: pathogenesis and treatment of chronic hepatic encephalopathy.

R Jalan1, J P Seery, S D Taylor-Robinson.   

Abstract

The various treatment strategies for hepatic encephalopathy are compared in the light of the available body of scientific work on the pathogenesis of the syndrome. Data on animal models of hepatic encephalopathy and in vitro studies on brain slices are discussed. Difficulties in extrapolating the results obtained to the human situation are highlighted, while results of human positron emission tomography and magnetic resonance spectroscopy studies are outlined on the background of the potential weaknesses of these non-invasive techniques.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899075     DOI: 10.1046/j.1365-2036.1996.58200000.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  14 in total

Review 1.  Hepatic encephalopathy as a complication of liver disease.

Authors:  S vom Dahl; G Kircheis; D Häussinger
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Liver disease and Helicobacter.

Authors:  Yu-Qin Luo; Jin-Bo Teng; Bo-Rong Pan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

3.  Helicobacter pylori, ammonia and the brain.

Authors:  S D Taylor-Robinson; N Jackson; C Buckley
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

4.  Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: a clinical rating scale.

Authors:  Sergei Mechtcheriakov; Ivo-W Graziadei; André Kugener; Julia Wiedemann; Chantal Galbavy; Hartmann Hinterhuber; Josef Marksteiner; Wolfgang Vogel
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

5.  Amino acid challenge in patients with cirrhosis and control subjects: ammonia, plasma amino acid and EEG changes.

Authors:  Hanan Al Mardini; Andrew Douglass; Christopher Record
Journal:  Metab Brain Dis       Date:  2006-05-04       Impact factor: 3.584

6.  (1)H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy.

Authors:  Konstantinos John Dabos; John Andrew Parkinson; Ian Howard Sadler; John Nicholas Plevris; Peter Clive Hayes
Journal:  World J Hepatol       Date:  2015-06-28

7.  Diagnostic value of fine motor deficits in patients with low-grade hepatic encephalopathy.

Authors:  Sergei Mechtcheriakov; Ivo W Graziadei; Maria Rettenbacher; Ingrid Schuster; Hartmann Hinterhuber; Wolfgang Vogel; Josef Marksteiner
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

8.  Clinical effects of rifaximin in patientswith hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study.

Authors:  Claudia Sama; Antonio Maria Morselli-Labate; Paolo Pianta; Laura Lambertini; Sonia Berardi; Gabriella Martini
Journal:  Curr Ther Res Clin Exp       Date:  2004-09

9.  Motor dysfunction in patients with liver cirrhosis: impairment of handwriting.

Authors:  Sergei Mechtcheriakov; Ivo W Graziadei; André Kugener; Ingrid Schuster; Joerg Mueller; Hartmann Hinterhuber; Wolfgang Vogel; Josef Marksteiner
Journal:  J Neurol       Date:  2005-10-28       Impact factor: 4.849

10.  The high prevalence of restless legs syndrome symptoms in liver disease in an academic-based hepatology practice.

Authors:  Rose A Franco; Ramesh Ashwathnarayan; Arshana Deshpandee; Joshua Knox; Jack Daniel; Daniel Eastwood; Jose Franco; Kia Saeian
Journal:  J Clin Sleep Med       Date:  2008-02-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.